カテゴリー： 世界, 医療/バイオ, LP Information

世界の甲状腺機能亢進症に対する抗甲状腺薬市場予測 2023年-2029年

【英語タイトル】Global Antithyroid Medications for Hyperthyroidism Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC07545）・商品コード：LP23DC07545
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の甲状腺機能亢進症に対する抗甲状腺薬市場」は、過去の販売実績から2022年の世界の甲状腺機能亢進症に対する抗甲状腺薬の総販売量を検討し、2023年から2029年の予測される甲状腺機能亢進症に対する抗甲状腺薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の甲状腺機能亢進症に対する抗甲状腺薬の市場規模を掲載し、XXX百万米ドル規模の世界の甲状腺機能亢進症に対する抗甲状腺薬市場の詳細な分析を提供します。本インサイトレポートは、世界の甲状腺機能亢進症に対する抗甲状腺薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の甲状腺機能亢進症に対する抗甲状腺薬市場における各社の独自のポジションをより深く理解するために、甲状腺機能亢進症に対する抗甲状腺薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の甲状腺機能亢進症に対する抗甲状腺薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。甲状腺機能亢進症に対する抗甲状腺薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。甲状腺機能亢進症に対する抗甲状腺薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。甲状腺機能亢進症に対する抗甲状腺薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

甲状腺機能亢進症に対する抗甲状腺薬の世界主要メーカーとしては、Merck、 Herbrand PharmaChemicals、 Future Health Pharma、 Shanghai Zhaohui Pharmaceutical、 Beijing Yanjing Pharmaceutical、 Jinghua Pharmaceutical Group、 Guangzhou Kanghe Pharmaceutical、 Zigong Honghe Pharmaceutical、 Guangdong Huanan Pharmaceutical、 Zibo Wankang Pharmaceutical Chemical、 Qilu Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の甲状腺機能亢進症に対する抗甲状腺薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では甲状腺機能亢進症に対する抗甲状腺薬市場をセグメンテーションし、種類別 (メチマゾール、プロピルチオウラシル、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：メチマゾール、プロピルチオウラシル、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の甲状腺機能亢進症に対する抗甲状腺薬市場の10年間の市場状況・展望は？
・世界および地域別に見た甲状腺機能亢進症に対する抗甲状腺薬市場成長の要因は何か？
・甲状腺機能亢進症に対する抗甲状腺薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・甲状腺機能亢進症に対する抗甲状腺薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：甲状腺機能亢進症に対する抗甲状腺薬の年間販売量2018-2029、地域別現状・将来分析
・甲状腺機能亢進症に対する抗甲状腺薬の種類別セグメント：メチマゾール、プロピルチオウラシル、その他
・甲状腺機能亢進症に対する抗甲状腺薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・甲状腺機能亢進症に対する抗甲状腺薬の用途別セグメント：病院、診療所、その他
・甲状腺機能亢進症に対する抗甲状腺薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の甲状腺機能亢進症に対する抗甲状腺薬市場
・企業別のグローバル甲状腺機能亢進症に対する抗甲状腺薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の甲状腺機能亢進症に対する抗甲状腺薬の年間売上：2018-2023年の売上、市場シェア
・企業別の甲状腺機能亢進症に対する抗甲状腺薬販売価格
・主要企業の甲状腺機能亢進症に対する抗甲状腺薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

甲状腺機能亢進症に対する抗甲状腺薬の地域別レビュー
・地域別の甲状腺機能亢進症に対する抗甲状腺薬市場規模2018-2023：年間販売量、売上
・主要国別の甲状腺機能亢進症に対する抗甲状腺薬市場規模2018-2023：年間販売量、売上
・南北アメリカの甲状腺機能亢進症に対する抗甲状腺薬販売の成長
・アジア太平洋の甲状腺機能亢進症に対する抗甲状腺薬販売の成長
・ヨーロッパの甲状腺機能亢進症に対する抗甲状腺薬販売の成長
・中東・アフリカの甲状腺機能亢進症に対する抗甲状腺薬販売の成長

南北アメリカ市場
・南北アメリカの国別の甲状腺機能亢進症に対する抗甲状腺薬販売量、売上（2018-2023）
・南北アメリカの甲状腺機能亢進症に対する抗甲状腺薬の種類別販売量
・南北アメリカの甲状腺機能亢進症に対する抗甲状腺薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の甲状腺機能亢進症に対する抗甲状腺薬販売量、売上（2018-2023）
・アジア太平洋の甲状腺機能亢進症に対する抗甲状腺薬の種類別販売量
・アジア太平洋の甲状腺機能亢進症に対する抗甲状腺薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の甲状腺機能亢進症に対する抗甲状腺薬販売量、売上（2018-2023）
・ヨーロッパの甲状腺機能亢進症に対する抗甲状腺薬の種類別販売量
・ヨーロッパの甲状腺機能亢進症に対する抗甲状腺薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の甲状腺機能亢進症に対する抗甲状腺薬販売量、売上（2018-2023）
・中東・アフリカの甲状腺機能亢進症に対する抗甲状腺薬の種類別販売量
・中東・アフリカの甲状腺機能亢進症に対する抗甲状腺薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・甲状腺機能亢進症に対する抗甲状腺薬の製造コスト構造分析
・甲状腺機能亢進症に対する抗甲状腺薬の製造プロセス分析
・甲状腺機能亢進症に対する抗甲状腺薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・甲状腺機能亢進症に対する抗甲状腺薬の主要なグローバル販売業者
・甲状腺機能亢進症に対する抗甲状腺薬の主要なグローバル顧客

地域別の甲状腺機能亢進症に対する抗甲状腺薬市場予測レビュー
・地域別の甲状腺機能亢進症に対する抗甲状腺薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・甲状腺機能亢進症に対する抗甲状腺薬の種類別市場規模予測
・甲状腺機能亢進症に対する抗甲状腺薬の用途別市場規模予測

主要企業分析
Merck、 Herbrand PharmaChemicals、 Future Health Pharma、 Shanghai Zhaohui Pharmaceutical、 Beijing Yanjing Pharmaceutical、 Jinghua Pharmaceutical Group、 Guangzhou Kanghe Pharmaceutical、 Zigong Honghe Pharmaceutical、 Guangdong Huanan Pharmaceutical、 Zibo Wankang Pharmaceutical Chemical、 Qilu Pharmaceutical
・企業情報
・甲状腺機能亢進症に対する抗甲状腺薬製品
・甲状腺機能亢進症に対する抗甲状腺薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Antithyroid Medications for Hyperthyroidism market size is projected to grow from US$ 443.1 million in 2022 to US$ 687.4 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.
United States market for Antithyroid Medications for Hyperthyroidism is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antithyroid Medications for Hyperthyroidism is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antithyroid Medications for Hyperthyroidism is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antithyroid Medications for Hyperthyroidism players cover Merck, Herbrand PharmaChemicals, Future Health Pharma, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical and Guangdong Huanan Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
LPI (LP Information)’ newest research report, the “Antithyroid Medications for Hyperthyroidism Industry Forecast” looks at past sales and reviews total world Antithyroid Medications for Hyperthyroidism sales in 2022, providing a comprehensive analysis by region and market sector of projected Antithyroid Medications for Hyperthyroidism sales for 2023 through 2029. With Antithyroid Medications for Hyperthyroidism sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antithyroid Medications for Hyperthyroidism industry.
This Insight Report provides a comprehensive analysis of the global Antithyroid Medications for Hyperthyroidism landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antithyroid Medications for Hyperthyroidism portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antithyroid Medications for Hyperthyroidism market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antithyroid Medications for Hyperthyroidism and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antithyroid Medications for Hyperthyroidism.
This report presents a comprehensive overview, market shares, and growth opportunities of Antithyroid Medications for Hyperthyroidism market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Methimazole
Propylthiouracil
Other
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
Herbrand PharmaChemicals
Future Health Pharma
Shanghai Zhaohui Pharmaceutical
Beijing Yanjing Pharmaceutical
Jinghua Pharmaceutical Group
Guangzhou Kanghe Pharmaceutical
Zigong Honghe Pharmaceutical
Guangdong Huanan Pharmaceutical
Zibo Wankang Pharmaceutical Chemical
Qilu Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antithyroid Medications for Hyperthyroidism market?
What factors are driving Antithyroid Medications for Hyperthyroidism market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antithyroid Medications for Hyperthyroidism market opportunities vary by end market size?
How does Antithyroid Medications for Hyperthyroidism break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antithyroid Medications for Hyperthyroidism by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antithyroid Medications for Hyperthyroidism by Country/Region, 2018, 2022 & 2029
2.2 Antithyroid Medications for Hyperthyroidism Segment by Type
2.2.1 Methimazole
2.2.2 Propylthiouracil
2.2.3 Other
2.3 Antithyroid Medications for Hyperthyroidism Sales by Type
2.3.1 Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
2.3.2 Global Antithyroid Medications for Hyperthyroidism Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antithyroid Medications for Hyperthyroidism Sale Price by Type (2018-2023)
2.4 Antithyroid Medications for Hyperthyroidism Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Antithyroid Medications for Hyperthyroidism Sales by Application
2.5.1 Global Antithyroid Medications for Hyperthyroidism Sale Market Share by Application (2018-2023)
2.5.2 Global Antithyroid Medications for Hyperthyroidism Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antithyroid Medications for Hyperthyroidism Sale Price by Application (2018-2023)
3 Global Antithyroid Medications for Hyperthyroidism by Company
3.1 Global Antithyroid Medications for Hyperthyroidism Breakdown Data by Company
3.1.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales by Company (2018-2023)
3.1.2 Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Company (2018-2023)
3.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue by Company (2018-2023)
3.2.1 Global Antithyroid Medications for Hyperthyroidism Revenue by Company (2018-2023)
3.2.2 Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Company (2018-2023)
3.3 Global Antithyroid Medications for Hyperthyroidism Sale Price by Company
3.4 Key Manufacturers Antithyroid Medications for Hyperthyroidism Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antithyroid Medications for Hyperthyroidism Product Location Distribution
3.4.2 Players Antithyroid Medications for Hyperthyroidism Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antithyroid Medications for Hyperthyroidism by Geographic Region
4.1 World Historic Antithyroid Medications for Hyperthyroidism Market Size by Geographic Region (2018-2023)
4.1.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antithyroid Medications for Hyperthyroidism Market Size by Country/Region (2018-2023)
4.2.1 Global Antithyroid Medications for Hyperthyroidism Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antithyroid Medications for Hyperthyroidism Sales Growth
4.4 APAC Antithyroid Medications for Hyperthyroidism Sales Growth
4.5 Europe Antithyroid Medications for Hyperthyroidism Sales Growth
4.6 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Growth
5 Americas
5.1 Americas Antithyroid Medications for Hyperthyroidism Sales by Country
5.1.1 Americas Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023)
5.1.2 Americas Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023)
5.2 Americas Antithyroid Medications for Hyperthyroidism Sales by Type
5.3 Americas Antithyroid Medications for Hyperthyroidism Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antithyroid Medications for Hyperthyroidism Sales by Region
6.1.1 APAC Antithyroid Medications for Hyperthyroidism Sales by Region (2018-2023)
6.1.2 APAC Antithyroid Medications for Hyperthyroidism Revenue by Region (2018-2023)
6.2 APAC Antithyroid Medications for Hyperthyroidism Sales by Type
6.3 APAC Antithyroid Medications for Hyperthyroidism Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antithyroid Medications for Hyperthyroidism by Country
7.1.1 Europe Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023)
7.1.2 Europe Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023)
7.2 Europe Antithyroid Medications for Hyperthyroidism Sales by Type
7.3 Europe Antithyroid Medications for Hyperthyroidism Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism by Country
8.1.1 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023)
8.2 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Type
8.3 Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antithyroid Medications for Hyperthyroidism
10.3 Manufacturing Process Analysis of Antithyroid Medications for Hyperthyroidism
10.4 Industry Chain Structure of Antithyroid Medications for Hyperthyroidism
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antithyroid Medications for Hyperthyroidism Distributors
11.3 Antithyroid Medications for Hyperthyroidism Customer
12 World Forecast Review for Antithyroid Medications for Hyperthyroidism by Geographic Region
12.1 Global Antithyroid Medications for Hyperthyroidism Market Size Forecast by Region
12.1.1 Global Antithyroid Medications for Hyperthyroidism Forecast by Region (2024-2029)
12.1.2 Global Antithyroid Medications for Hyperthyroidism Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antithyroid Medications for Hyperthyroidism Forecast by Type
12.7 Global Antithyroid Medications for Hyperthyroidism Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.1.3 Merck Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Herbrand PharmaChemicals
13.2.1 Herbrand PharmaChemicals Company Information
13.2.2 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.2.3 Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Herbrand PharmaChemicals Main Business Overview
13.2.5 Herbrand PharmaChemicals Latest Developments
13.3 Future Health Pharma
13.3.1 Future Health Pharma Company Information
13.3.2 Future Health Pharma Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.3.3 Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Future Health Pharma Main Business Overview
13.3.5 Future Health Pharma Latest Developments
13.4 Shanghai Zhaohui Pharmaceutical
13.4.1 Shanghai Zhaohui Pharmaceutical Company Information
13.4.2 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.4.3 Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.4.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.5 Beijing Yanjing Pharmaceutical
13.5.1 Beijing Yanjing Pharmaceutical Company Information
13.5.2 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.5.3 Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing Yanjing Pharmaceutical Main Business Overview
13.5.5 Beijing Yanjing Pharmaceutical Latest Developments
13.6 Jinghua Pharmaceutical Group
13.6.1 Jinghua Pharmaceutical Group Company Information
13.6.2 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.6.3 Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Jinghua Pharmaceutical Group Main Business Overview
13.6.5 Jinghua Pharmaceutical Group Latest Developments
13.7 Guangzhou Kanghe Pharmaceutical
13.7.1 Guangzhou Kanghe Pharmaceutical Company Information
13.7.2 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.7.3 Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Guangzhou Kanghe Pharmaceutical Main Business Overview
13.7.5 Guangzhou Kanghe Pharmaceutical Latest Developments
13.8 Zigong Honghe Pharmaceutical
13.8.1 Zigong Honghe Pharmaceutical Company Information
13.8.2 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.8.3 Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Zigong Honghe Pharmaceutical Main Business Overview
13.8.5 Zigong Honghe Pharmaceutical Latest Developments
13.9 Guangdong Huanan Pharmaceutical
13.9.1 Guangdong Huanan Pharmaceutical Company Information
13.9.2 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.9.3 Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Guangdong Huanan Pharmaceutical Main Business Overview
13.9.5 Guangdong Huanan Pharmaceutical Latest Developments
13.10 Zibo Wankang Pharmaceutical Chemical
13.10.1 Zibo Wankang Pharmaceutical Chemical Company Information
13.10.2 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.10.3 Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Zibo Wankang Pharmaceutical Chemical Main Business Overview
13.10.5 Zibo Wankang Pharmaceutical Chemical Latest Developments
13.11 Qilu Pharmaceutical
13.11.1 Qilu Pharmaceutical Company Information
13.11.2 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
13.11.3 Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Qilu Pharmaceutical Main Business Overview
13.11.5 Qilu Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Antithyroid Medications for Hyperthyroidism Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antithyroid Medications for Hyperthyroidism Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Methimazole
Table 4. Major Players of Propylthiouracil
Table 5. Major Players of Other
Table 6. Global Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 7. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Table 8. Global Antithyroid Medications for Hyperthyroidism Revenue by Type (2018-2023) & ($ million)
Table 9. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Type (2018-2023)
Table 10. Global Antithyroid Medications for Hyperthyroidism Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 12. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Table 13. Global Antithyroid Medications for Hyperthyroidism Revenue by Application (2018-2023)
Table 14. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Application (2018-2023)
Table 15. Global Antithyroid Medications for Hyperthyroidism Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Antithyroid Medications for Hyperthyroidism Sales by Company (2018-2023) & (K Units)
Table 17. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Company (2018-2023)
Table 18. Global Antithyroid Medications for Hyperthyroidism Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Company (2018-2023)
Table 20. Global Antithyroid Medications for Hyperthyroidism Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Antithyroid Medications for Hyperthyroidism Producing Area Distribution and Sales Area
Table 22. Players Antithyroid Medications for Hyperthyroidism Products Offered
Table 23. Antithyroid Medications for Hyperthyroidism Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Antithyroid Medications for Hyperthyroidism Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Antithyroid Medications for Hyperthyroidism Sales Market Share Geographic Region (2018-2023)
Table 28. Global Antithyroid Medications for Hyperthyroidism Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Antithyroid Medications for Hyperthyroidism Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Country/Region (2018-2023)
Table 32. Global Antithyroid Medications for Hyperthyroidism Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023) & (K Units)
Table 35. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Country (2018-2023)
Table 36. Americas Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country (2018-2023)
Table 38. Americas Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 39. Americas Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 40. APAC Antithyroid Medications for Hyperthyroidism Sales by Region (2018-2023) & (K Units)
Table 41. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Region (2018-2023)
Table 42. APAC Antithyroid Medications for Hyperthyroidism Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Antithyroid Medications for Hyperthyroidism Revenue Market Share by Region (2018-2023)
Table 44. APAC Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 45. APAC Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 46. Europe Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023) & (K Units)
Table 47. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Country (2018-2023)
Table 48. Europe Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country (2018-2023)
Table 50. Europe Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 51. Europe Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Antithyroid Medications for Hyperthyroidism
Table 59. Key Market Challenges & Risks of Antithyroid Medications for Hyperthyroidism
Table 60. Key Industry Trends of Antithyroid Medications for Hyperthyroidism
Table 61. Antithyroid Medications for Hyperthyroidism Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Antithyroid Medications for Hyperthyroidism Distributors List
Table 64. Antithyroid Medications for Hyperthyroidism Customer List
Table 65. Global Antithyroid Medications for Hyperthyroidism Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Antithyroid Medications for Hyperthyroidism Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Antithyroid Medications for Hyperthyroidism Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Antithyroid Medications for Hyperthyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Antithyroid Medications for Hyperthyroidism Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Antithyroid Medications for Hyperthyroidism Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Antithyroid Medications for Hyperthyroidism Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Antithyroid Medications for Hyperthyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Antithyroid Medications for Hyperthyroidism Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Antithyroid Medications for Hyperthyroidism Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Antithyroid Medications for Hyperthyroidism Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Antithyroid Medications for Hyperthyroidism Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 81. Merck Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Herbrand PharmaChemicals Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 85. Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 86. Herbrand PharmaChemicals Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Herbrand PharmaChemicals Main Business
Table 88. Herbrand PharmaChemicals Latest Developments
Table 89. Future Health Pharma Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 90. Future Health Pharma Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 91. Future Health Pharma Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Future Health Pharma Main Business
Table 93. Future Health Pharma Latest Developments
Table 94. Shanghai Zhaohui Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 95. Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 96. Shanghai Zhaohui Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Shanghai Zhaohui Pharmaceutical Main Business
Table 98. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 99. Beijing Yanjing Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 100. Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 101. Beijing Yanjing Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Beijing Yanjing Pharmaceutical Main Business
Table 103. Beijing Yanjing Pharmaceutical Latest Developments
Table 104. Jinghua Pharmaceutical Group Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 105. Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 106. Jinghua Pharmaceutical Group Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Jinghua Pharmaceutical Group Main Business
Table 108. Jinghua Pharmaceutical Group Latest Developments
Table 109. Guangzhou Kanghe Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 110. Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 111. Guangzhou Kanghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Guangzhou Kanghe Pharmaceutical Main Business
Table 113. Guangzhou Kanghe Pharmaceutical Latest Developments
Table 114. Zigong Honghe Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 115. Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 116. Zigong Honghe Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Zigong Honghe Pharmaceutical Main Business
Table 118. Zigong Honghe Pharmaceutical Latest Developments
Table 119. Guangdong Huanan Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 120. Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 121. Guangdong Huanan Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Guangdong Huanan Pharmaceutical Main Business
Table 123. Guangdong Huanan Pharmaceutical Latest Developments
Table 124. Zibo Wankang Pharmaceutical Chemical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 125. Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 126. Zibo Wankang Pharmaceutical Chemical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Zibo Wankang Pharmaceutical Chemical Main Business
Table 128. Zibo Wankang Pharmaceutical Chemical Latest Developments
Table 129. Qilu Pharmaceutical Basic Information, Antithyroid Medications for Hyperthyroidism Manufacturing Base, Sales Area and Its Competitors
Table 130. Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Product Portfolios and Specifications
Table 131. Qilu Pharmaceutical Antithyroid Medications for Hyperthyroidism Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Qilu Pharmaceutical Main Business
Table 133. Qilu Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Antithyroid Medications for Hyperthyroidism
Figure 2. Antithyroid Medications for Hyperthyroidism Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antithyroid Medications for Hyperthyroidism Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antithyroid Medications for Hyperthyroidism Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antithyroid Medications for Hyperthyroidism Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Methimazole
Figure 10. Product Picture of Propylthiouracil
Figure 11. Product Picture of Other
Figure 12. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Type in 2022
Figure 13. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Type (2018-2023)
Figure 14. Antithyroid Medications for Hyperthyroidism Consumed in Hospital
Figure 15. Global Antithyroid Medications for Hyperthyroidism Market: Hospital (2018-2023) & (K Units)
Figure 16. Antithyroid Medications for Hyperthyroidism Consumed in Clinic
Figure 17. Global Antithyroid Medications for Hyperthyroidism Market: Clinic (2018-2023) & (K Units)
Figure 18. Antithyroid Medications for Hyperthyroidism Consumed in Other
Figure 19. Global Antithyroid Medications for Hyperthyroidism Market: Other (2018-2023) & (K Units)
Figure 20. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2022)
Figure 21. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Application in 2022
Figure 22. Antithyroid Medications for Hyperthyroidism Sales Market by Company in 2022 (K Units)
Figure 23. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Company in 2022
Figure 24. Antithyroid Medications for Hyperthyroidism Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Company in 2022
Figure 26. Global Antithyroid Medications for Hyperthyroidism Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 29. Americas Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 30. APAC Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 31. APAC Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 32. Europe Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 33. Europe Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue 2018-2023 ($ Millions)
Figure 36. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Country in 2022
Figure 37. Americas Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country in 2022
Figure 38. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 39. Americas Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 40. United States Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Region in 2022
Figure 45. APAC Antithyroid Medications for Hyperthyroidism Revenue Market Share by Regions in 2022
Figure 46. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 47. APAC Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 48. China Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Country in 2022
Figure 56. Europe Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country in 2022
Figure 57. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 58. Europe Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 59. Germany Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Antithyroid Medications for Hyperthyroidism Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Antithyroid Medications for Hyperthyroidism Sales Market Share by Application (2018-2023)
Figure 68. Egypt Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Antithyroid Medications for Hyperthyroidism Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Antithyroid Medications for Hyperthyroidism in 2022
Figure 74. Manufacturing Process Analysis of Antithyroid Medications for Hyperthyroidism
Figure 75. Industry Chain Structure of Antithyroid Medications for Hyperthyroidism
Figure 76. Channels of Distribution
Figure 77. Global Antithyroid Medications for Hyperthyroidism Sales Market Forecast by Region (2024-2029)
Figure 78. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Antithyroid Medications for Hyperthyroidism Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Antithyroid Medications for Hyperthyroidism Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Antithyroid Medications for Hyperthyroidism Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の甲状腺機能亢進症に対する抗甲状腺薬市場予測 2023年-2029年] (コード：LP23DC07545)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の甲状腺機能亢進症に対する抗甲状腺薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の自閉症スペクトラム障害用治療薬市場予測 2023年-2029年
  • 世界の医薬品用塩酸ベニジピン市場予測 2023年-2029年
  • 世界の医薬品用プリロカイン市場予測 2023年-2029年
  • 世界の医薬品用造粒装置市場予測 2023年-2029年
  • 世界の医薬品用充填針市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆